Brind.
  1. IGC Pharma, Inc. is leveraging AI platforms like MINT-AD for drug discovery, coinciding with the AAIC 2025 conference in Toronto.

IGC Pharma, Inc. reported an operational bottleneck during engine development while also developing a proprietary enterprise software platform.

1 report, 1 independent Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

IGC Pharma, Inc. reported an operational bottleneck during engine development while also developing a proprietary enterprise software platform.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped